Botulinum Toxin as a novel addition to the antidupuytren armamentarium

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 240-241

  Namazi, Hamid ^a   Abdinejad, Farzad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BASIC FIBROBLAST GROWTH FACTOR; BOTULINUM TOXIN; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; RHO GUANOSINE TRIPHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA;

DRUG EFFECT; DRUG MECHANISM; DUPUYTREN CONTRACTURE; ENZYME INHIBITION; FIBROSIS; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL;

EID: 33751105912     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.01.025     Document Type: Letter

References (6)

1. McGrouthier D.A. Dupuytren's contracture. Green's operative hand surgery. 5th ed. (2005), Churchill Livingstone
2. Kloen P., Jennings C.L., Gebhardt M., et al. Transforming growth factor-Beta: posssible role in Dupuytren's contracture. J Hand Surg (Am) 20 1 (1995) 101-108
3. Bayat A., Watson J.S., Stanely J.K., et al. Genetic susceptibility to dupuytren disease, association of ZF9 transcription factor gene. Plast Reconstr Surg 11 7 (2003) 211-219
4. Baird K.S., Crossan J.F., and Ralston S.H. Abnormal growth factors and cytokine expression in Dupuytren's contracture. J Clin Pathol 46 5 (1996) 415-418
5. Singh R., Wang B., Shirvaikar A., et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103 11 (1999) 1561-1570
6. Harmey D., Stenbeck G., Nobes C.D., et al. Regulation of osteoblast differentiation by Pasteurella multocida toxin: a role for Rho GTPase in bone formation. J Bone Miner Res 19 4 (2004) 661-670